Posts with tag Paediatrics

This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation. To view our first article and the whole series, please click here. Reforming legislation is rarely a straightforward task.  In the context of legislation governing medicines, countless stakeholders have a diverse range of interests and ambitions: patients need to be protected, and all without stifling future research...